Pembrolizumab (Pembro) Vs Standard of Care (Soc) for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M Hnscc): Phase 3 Keynote-040 Trial
AuthID
P-00N-2XR
P-00N-2XR
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service